Eli Lilly says its drug cuts COVID risk in nursing homes

preview_player
Показать описание
Drugmaker Eli Lilly said a trial of its antibody drug, bamlanivimab, showed it can reduce the risk of COVID-19 by 80% for nursing home residents.


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

#COVID19 #News
Рекомендации по теме